Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker
Translational Oncology · 2024-03 · 41 · 101882
DOI: 10.1016/j.tranon.2024.101882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2024-03. Verfasst von Tiantian Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, China; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong Universit…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Huazhong University of Science and Technology.
Abstract (Originalsprache)
ABCC1 belongs to the ATP-binding cassette (ABC) superfamily, which encompasses a total of 48 constituent members. ABCC1 has been shown to be associated with the growth, progression, and drug resistance of various types of cancer. However, the impact of ABCC1 on cancer immune infiltration and pan-cancer prognosis has been rarely studied. Our comprehensive pan-cancer analysis unveiled elevated ABCC1 expression across various cancers. ABCC1 overexpression consistently predicted unfavorable outcomes based on TCGA data. Moreover, ABCC1 expression exhibited intricate associations with diverse immune-related genes and demonstrated a close correlation with immune scores across multiple tumor types. Analysis of scRNA-seq data from the GEO database revealed that the expression of ABCC1 in hepatocellular carcinoma (HCC) cells is significant positively correlated with macrophage infiltration. Furthermore, various in vitro and in vivo experiments substantiated the role of ABCC1 in promoting the progression of HCC, along with increased macrophage recruitment. Based on the results, we propose ABCC1 as a potentially valuable prognostic indicator and a prospective target for immune-based cancer therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, China; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China; Clinical Medicine Research Center…
- Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Huazhong University of Science and Technology
Zitieren
APA
Wang, T., Rao, D., Fu, C., Luo, Y., Lu, J., Liang, H., Xia, L., & Huang, W. (2024). Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker. Translational Oncology, 41, 101882. https://doi.org/10.1016/j.tranon.2024.101882
Vancouver
Wang T, Rao D, Fu C, Luo Y, Lu J, Liang H, et al. Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker. Translational Oncology. 2024;41:101882. doi:10.1016/j.tranon.2024.101882
BibTeX
@article{Wang2024,
author = {Wang, Tiantian and Rao, Dean and Fu, Chenan and Luo, Yiming and Lu, Junli and Liang, Huifang and Xia, Limin and Huang, Wenjie},
title = {Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker},
journal = {Translational Oncology},
year = {2024},
volume = {41},
pages = {101882},
doi = {10.1016/j.tranon.2024.101882}
}
EUVIMED